IL6 and hepatocellular carcinoma: Blockage of IL6 and IGF-1R activation disrupts expression of cancer stemness properties in vitro and in vivo, indicating that the inflammatory niche of IL6 promotes early recurrence through IGF-1R activation in patients with HBV-HCC [223].